These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7947259)

  • 1. An autoantibody to human plasma prekallikrein blocks activation of the contact system.
    Page JD; DeLa Cadena RA; Humphries JE; Colman RW
    Br J Haematol; 1994 May; 87(1):81-6. PubMed ID: 7947259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
    Page JD; Colman RW
    J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity.
    Reddigari SR; Kaplan AP
    Blood; 1989 Aug; 74(2):695-702. PubMed ID: 2752143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
    Veloso D; Silver LD; Hahn S; Colman RW
    Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens.
    Sugi T; McIntyre JA
    J Autoimmun; 2001 Nov; 17(3):207-14. PubMed ID: 11712858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.
    Scott CF; Colman RW
    J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma.
    Reddigari S; Kaplan AP
    Blood; 1988 May; 71(5):1334-40. PubMed ID: 2451949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure, kinetics, and function of human and rhesus plasma prekallikreins are similar.
    Veloso D; Smith JI; Denny S; Cosgriff TM
    Thromb Haemost; 1992 Nov; 68(5):526-33. PubMed ID: 1455399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prekallikrein deficiency: the characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII.
    Asmis LM; Sulzer I; Furlan M; Lämmle B
    Thromb Res; 2002 Mar; 105(6):463-70. PubMed ID: 12091043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
    Joseph K; Tholanikunnel BG; Kaplan AP
    J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of a variant prekallikrein (PK Zürich).
    Wuillemin WA; Furlan M; von Felten A; Lämmle B
    Thromb Haemost; 1993 Sep; 70(3):427-32. PubMed ID: 8259543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System.
    Riano I; Prasongdee K
    J Investig Med High Impact Case Rep; 2021; 9():23247096211012187. PubMed ID: 33940978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prekallikrein deficiency in a family of miniature horses.
    Turrentine MA; Sculley PW; Green EM; Johnson GS
    Am J Vet Res; 1986 Nov; 47(11):2464-7. PubMed ID: 3641551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus.
    Kalter ES; van Dijk WC; Timmerman A; Verhoef J; Bouma BN
    J Infect Dis; 1983 Oct; 148(4):682-91. PubMed ID: 6355312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage.
    Citarella F; Wuillemin WA; Lubbers YT; Hack CE
    Br J Haematol; 1997 Oct; 99(1):197-205. PubMed ID: 9359524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinin-generating cascade in advanced cancer patients and in vitro study.
    Matsumura Y; Maruo K; Kimura M; Yamamoto T; Konno T; Maeda H
    Jpn J Cancer Res; 1991 Jun; 82(6):732-41. PubMed ID: 1906858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.
    Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S
    J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.